BURNING ROCK DX
LIVE

Serial Number

90803035

Owner

Guangzhou Burning Rock Dx Co., Ltd.

Attorney

Brett Heavner

First Use Date

Apr 25, 2025

Filing Date

Jun 30, 2021

Add to watchlist:

No watchlists yet
View on USPTO

BURNING ROCK DX Trademark

Serial Number: 90803035 • Registration: 8355810

BURNING ROCK DX is a trademark filed by Guangzhou Burning Rock Dx Co., Ltd. on June 30, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Guangzhou Burning Rock Dx Co., Ltd. (8 trademarks)

Units 201-202, 2nd Floor, No. 7 Luoxuan 4th Road,

Entity Type: 99

Trademark Details

Filing Date

June 30, 2021

Registration Date

July 21, 2026

First Use Anywhere

April 25, 2025

First Use in Commerce

April 25, 2025

Published for Opposition

May 2, 2023

Goods & Services

medical analysis services for diagnostic and treatment purposes provided by medical laboratories; telemedicine services; medical screening; genetic testing for medical purposes

educational services, namely, providing seminars and workshops in the field of medical technology and medical training; instruction in the field of medical technology and medical training; arranging and conducting of conferences in the field of medical technology and medical training; educational and entertainment services, namely, providing motivational and educational speakers in the field of medicine

biological preparations for medical purposes, namely, biological preparations for detecting genetic predispositions for medical purposes; biological diagnostic preparations for medical purposes, namely, biological preparations for detecting the presence of cancer through blood and body fluid testing; diagnostic biomarker reagents for medical purposes; chemical preparations for medical purposes, namely, diagnostic reagents for medical use, diagnostic biomarker reagents for medical purposes, diagnostic agents, medical diagnostic reagents for the analysis of body fluids, reagents and media for medical and veterinary diagnostic purposes, diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; diagnostic preparations for medical purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 21, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 21, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 1, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 1, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 17, 2026 SUPC
USE AMENDMENT FILED
Jun 16, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 16, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 20, 2026 EXRA
SOU EXTENSION 5 GRANTED
May 19, 2026 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 19, 2026 AITU
SOU TEAS EXTENSION RECEIVED
Dec 18, 2025 EEXT
SOU EXTENSION 5 FILED
Dec 17, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 28, 2025 EXRA
SOU EXTENSION 4 GRANTED
Jun 27, 2025 EX4G
SOU EXTENSION 4 FILED
Jun 27, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 27, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 16, 2024 EXRA
SOU EXTENSION 3 GRANTED
Dec 16, 2024 EX3G
SOU EXTENSION 3 FILED
Dec 16, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 16, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 27, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jun 27, 2024 EX2G
SOU EXTENSION 2 FILED
Jun 27, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 27, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 29, 2023 EXRA
SOU EXTENSION 1 GRANTED
Dec 27, 2023 EX1G
SOU EXTENSION 1 FILED
Dec 27, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 27, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 27, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 2, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 2, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 12, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 29, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 29, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 29, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 29, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 29, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 28, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 28, 2023 TROA
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Feb 23, 2023 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 23, 2023 PARI
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 7, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 7, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 7, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 13, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 13, 2022 CRFA
ASSIGNED TO LIE
Aug 12, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 19, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 23, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 23, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 23, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 12, 2021 NWOS
NEW APPLICATION ENTERED
Jul 3, 2021 NWAP